Established in May 2016, The AMR Centre is a key part of the UK’s response to the global threat from Antimicrobial Resistance. Based at Alderley Park, The AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept.
Breaking News
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma company Shionogi to take forward its anti-virulence program, COT-143.
AMR Centre to join first life sciences delegation to Biomed in Israel
The North’s life sciences landscape will be showcased on an international stage at a leading Israeli medtech conference.
The AMR Centre secures £2.3m funding boost
The AMR Centre has received a significant funding package to support the expansion of its pipeline of new drugs to treat drug-resistant infections.
Latest News
The AMR Centre set for partnership with Shionogi for new superbug therapy
The AMR Centre Ltd has today announced a landmark agreement with the Japanese pharma…
Partnering for 2019
The AMR Centre is searching for new collaborative opportunities throughout 2019.
AMR Centre marks UN International Day of Women and Girls in Science
Today marks the official UN International Day of Women and Girls in Science.
AMR Centre hails government action plan as ‘critical step’ in tackling antibiotic crisis
Today’s announcement by the UK Government on the launch of a trial to evaluate a new way…
International Trade Minister visits AMR Centre
The AMR Centre was delighted to welcome Baroness Rona Fairhead to Alderley Park, where…
Industry group calls for action over £500m funding gap on AMR
A life science industry report representing 36 key businesses and organisations concerned…
Health Select Committee urges redoubling efforts to tackle antibiotic crisis
The AMR Centre has welcomed a new report today from the House of Commons Health and…
BIA report highlights importance of SMEs in global antibiotics challenge
The AMR Centre has today welcomed a new report from the BioIndustry Association (BIA),…
